FNCHQ — Finch Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $16.62m
- $0.58m
- $0.11m
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp
Finch Therapeutics falls on 1-for-30 reverse stock split
Brief: Finch Announces Reverse Stock Split Of Common Stock
Brief: Finch Therapeutics Reports Q1 2023 Financial Results And Provides Business Updates
Brief: Finch Therapeutics Group Inc - Matthew P. Blischak Appointed As Chief Executive Officer Effective May 16, 2023
Brief: Finch Therapeutics Announces Clinical Collaboration In Ulcerative Colitis With Brigham And Women Hospital
Brief: Finch Therapeutics Group Inc Reports Quarterly Loss Per Share Of $0.56
U.S. STOCKS ON THE MOVE-Baudax Bio , GATX Corp, Verb Technology, Decibel Therapeutics
Finch Therapeutics falls on discontinuing bacterial infection drug trial
Brief: Finch Therapeutics Announces Decision To Discontinue Phase 3 Trial Of Cp101 And Focus On Realizing The Value Of Its Intellectual Property Estate And Other Assets
Brief: Finch Therapeutics Group Inc - As A Result Of Restructuring Estimates That It Will Incur Approximately $4.1 Million In Costs
Brief: Finch Therapeutics Receives Nasdaq Notice
Brief: Finch Therapeutics Reports Q3 2022 Financial Results
Brief: Finch Therapeutics Presents PRISM-EXT biomarker Data At ACG 2022
Finch Therapeutics down on restructuring plans
Brief: Finch Therapeutics To Reduce Workforce By About 37%